Records 1 - 3
| Assessing the contribution of opioid- and dopamine-related genetic polymorphisms to the abuse liability of oxycodone.
Pharmacology, biochemistry, and behavior 2019 Sep 172778.
Jones Jermaine D, Mumtaz Mudassir, Manubay Jeanne M, Mogali Shanthi, Sherwin Elliana, Martinez Suky, Comer Sandra
| Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia.
Journal of psychiatric research 2016 Nov 86 9-17.
Eisenstein Sarah A, Bogdan Ryan, Chen Ling, Moerlein Stephen M, Black Kevin J, Perlmutter Joel S, Hershey Tamara, Barch Deanna
| The mediating effect of prefrontal asymmetry on the relationship between the COMT Val(158)Met SNP and trait consummatory positive affect.
Cognition & emotion 2015 29 (5): 867-81.
Katz Andrea C, Sarapas Casey, Bishop Jeffrey R, Patel Shitalben R, Shankman Stewart